During the past decade, Sarkis Clinical Trials conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sarkis Clinical Trials" #1 sponsor was "Tonix Pharmaceuticals, Inc." with 2 trials, followed by "Indivior Inc." with 1 trials sponsored, "Janssen Research & Development, LLC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Shire" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "Sarkis Clinical Trials" are "PTSD" (2 trials), "Attention-deficit/Hyperactivity Disorder" (1 trials), "Generalized Anxiety Disorder" (1 trials), "Insomnia Disorders" (1 trials) and "Opioid Use Disorder" (1 trials). Many other conditions were trialed in "Sarkis Clinical Trials" in a lesser frequency.

Most popular intervention types in "Sarkis Clinical Trials" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "TNX-102 SL" (2 trials), "JNJ-42847922, 10 mg" (1 trials), "JNJ-42847922, 20 mg" (1 trials) and "JNJ-42847922, 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sarkis Clinical Trials" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Sarkis Clinical Trials". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Sarkis Clinical Trials, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sarkis Clinical Trials, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".